Uday Kumar, founder and Chief Medical Officer of iRhythm, discusses how he and his team proactively sought opportunities to add value to the healthcare system during needs exploration.

Uday Kumar, founder and Chief Medical Officer of iRhythm, explains how his team’s early focus on value factored into need selection and the development of need criteria.

Uday Kumar, founder and Chief Medical Officer of iRhythm, describes the solution he and his teammates devised to address the value opportunity they uncovered during needs exploration.

Uday Kumar, founder and Chief Medical Officer of iRhythm, describes his interactions with his university’s Office of Technology Licensing as he and his team were initially working on their concept and after he decided to take the idea forward.

Uday Kumar, founder and Chief Medical Officer of iRhythm, explains some of the key components of a typical OTL license.

Uday Kumar, founder and Chief Medical Officer of iRhythm, highlights some key considerations in negotiating and proactively managing an OTL license.

Uday Kumar, founder and Chief Medical Officer of iRhythm, describes how a university Office of Technology Licensing can be a helpful resource when it comes to start-up funding.

Uday Kumar, founder and Chief Medical Officer of iRhythm, provides an overview of the stakeholders in atrial fibrillation and an example of a high-level flow of money analysis.

Faculty and fellows from the Stanford Biodesign program describe the concept generation stage of the biodesign innovation process and how to make the most of these activities.

Faculty and fellows from the Stanford Biodesign program outline the fundamentals of concept screening and provide advice for deciding which solution to take forward in the biodesign innovation process.